Autopsy and Case Reports
Autopsy and Case Reports
Autopsy Case Report

Carnitine-acylcarnitine translocase deficiency: a case report with autopsy

Chennakeshava Thunga; Suvradeep Mitra; Devi Dayal; Sadhna Lal

Downloads: 1
Views: 271


Fatty acid oxidation defects are a heterogeneous group of disorders related to the mitochondrial fatty acid oxidation pathway. Carnitine acylcarnitine translocase (CACT) is an enzyme responsible for the unidirectional transport of acylcarnitine across the inner mitochondrial membrane. This enzyme plays a crucial role in the oxidation of fatty acids. The autopsy pathology of the CACT deficiency is described in only a few cases. We describe the autopsy pathology of a child with CACT deficiency dominantly in the form of microvesicular steatosis of the hepatocytes, renal proximal tubular epithelia, cardiac myocytes, and rhabdomyocytes. The diagnosis was further confirmed on whole exome sequencing with compound heterozygous variants in the exon 1 (c.82G>T, p.Gly28Cys; likely pathogenic) and exon 5 (c.535G>A, p.Asp179Asn; uncertain significance) of the SLC25A20 gene. This case elucidates the histopathology of the liver and the detailed autopsy of a case of CACT deficiency from India.


Autopsy, Fatty liver, Pathology


1 Yamamoto T, Mishima H, Mizukami H, et al. Metabolic autopsy with next generation sequencing in sudden unexpected death in infancy: postmortem diagnosis of fatty acid oxidation disorders. Mol Genet Metab Rep. 2015;5:26-32. PMid:28649538.

2 Rinaldo P, Yoon HR, Yu C, Raymond K, Tiozzo C, Giordano G. Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol. 1999;23(2):204-10. PMid:10331471.

3 Vitoria I, Martín-Hernández E, Peña-Quintana L, et al. Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature. JIMD Rep. 2015;20:11-20. PMid:25614308.

4 Lee RS, Lam CW, Lai CK, et al. Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest. Hong Kong Med J. 2007;13(1):66-8. PMid:17277394.

5 Yan HM, Hu H, Ahmed A, et al. Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: two case reports and brief literature review. Medicine. 2017;96(45):e8549. PMid:29137068.

6 Ryder B, Inbar-Feigenberg M, Glamuzina E, et al. New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: management challenges and potential therapeutic approaches. J Inherit Metab Dis. 2021;44(4):903-15. PMid:33634872.

7 Li N, Zhao H. Role of carnitine in non-alcoholic fatty liver disease and other related diseases: an update. Front Med. 2021;8:689042. PMid:34434943.

8 Bonnefont JP, Demaugre F, Prip-Buus C, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab. 1999;68(4):424-40. PMid:10607472.

9 Hegarty R, Deheragoda M, Fitzpatrick E, Dhawan A. Paediatric fatty liver disease (PeFLD): all is not NAFLD - Pathophysiological insights and approach to management. J Hepatol. 2018;68(6):1286-99. PMid:29471012.

10 Li X, Zhao F, Zhao Z, et al. Neonatal sudden death caused by a novel heterozygous mutation in SLC25A20 gene: a case report and brief literature review. Leg Med. 2022;54:101990. PMid:34784499.

11 Caldart F, de Pretis N, Luchini C, Ciccocioppo R, Frulloni L. Pancreatic steatosis and metabolic pancreatic disease: a new entity? Intern Emerg Med. 2023;18(8):2199-208. PMid:37462859.

12 Costa C, Costa JM, Slama A, et al. Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency. Mol Genet Metab. 2003;78(1):68-73. PMid:12559850.

13 Norris MK, Scott AI, Sullivan S, et al. Tutorial: triheptanoin and nutrition management for treatment of long-chain fatty acid oxidation disorders. JPEN J Parenter Enteral Nutr. 2021;45(2):230-8. PMid:33085788.

Submitted date:

Accepted date:

Publication date:

660f00d2a953952f082863f3 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections